Chia seed (Salvia hispanica) has become a familiar ingredient in breads, cereals, snack foods, smoothies and other products. But as consumption has increased, evidence is emerging that it may also need greater attention as a potential food allergen.
A recent review brings together the limited clinical and molecular evidence on chia allergy. So far, clinical evidence consists of only a small number of case reports, conference reports and one case series, but reactions described include immediate IgE-mediated symptoms, skin reactions and anaphylaxis.
Researchers have also identified several families of chia proteins with allergenic potential. Of particular interest is evidence of IgE cross-reactivity between chia and sesame. However, the authors caution that laboratory evidence of cross-recognition does not necessarily mean that someone with sesame allergy will have a clinical reaction to chia.
Significant knowledge gaps remain. The prevalence of chia allergy is unknown, as are reaction thresholds and its natural history. There are also currently no standardised diagnostic extracts, validated specific-IgE thresholds or chia-specific oral food challenge protocols.
For now, the evidence supports chia as a potential emerging allergen rather than an established widespread allergy risk. Its growing use in foods, however, makes further clinical research and surveillance important.
Reference: Porr et al. Chia Seed Allergy: Emerging Clinical Evidence, Molecular Allergens, and the Unresolved Question of Cross-Reactivity. Nutrients, 18(18), 3027 (2026). DOI: 10.3390/nu18183027. Available with Open Access here.
